Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)

Clinical trial NCT01147250 · COMPLETED

Trial details

NCT number: NCT01147250
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Coronary Syndrome

Start date: 2010-06-01
Primary completion: 2015-02-01
Enrollment: 6068

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.